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Background: Striatocapsular infarcts (SCIs) are defined as large subcortical infarcts 
involving the territory of more than one lenticulostriate artery. SCI without concomitant 
ischemia in the more distal middle cerebral artery (MCA) territory [isolated SCI (iSCI)] 
has been described as a rare infarct pattern. The purpose of this study was to assess 
the prevalence of iSCI in patients treated with endovascular thrombectomy (ET), to eval-
uate baseline and procedural parameters associated with this condition, and to describe 
the clinical course of iSCI patients.
Methods: A retrospective analysis of 206 consecutive patients with an isolated MCA 
occlusion involving the lenticulostriate arteries and treated with ET was performed. 
Baseline patient and procedural characteristics and ischemic involvement of the stria-
tocapsular and distal MCA territory [iSCI, as opposed to non-isolated SCI (niSCI)] were 
analyzed using multivariate logistic regression models. Prevalence of iSCI was assessed, 
and clinical course was determined with the rates of substantial neurological improve-
ment and good functional short- and mid-term outcome (discharge/day 90 Modified 
Rankin Scale ≤2).
results: iSCI was detected in 53 patients (25.7%), and niSCI was detected in 153 
patients (74.3%). Successful reperfusion [thrombolysis in cerebral infarction (TICI) 2b/3] 
[adjusted odds ration (aOR) 8.730, 95% confidence interval (95% CI) 1.069–71.308] 
and good collaterals (aOR 2.100, 95% CI 1.119–3.944) were associated with iSCI. In 
successfully reperfused patients, TICI 3 was found to be an additional factor associated 
with iSCI (aOR 5.282, 1.759–15.859). Patients with iSCI had higher rates of substantial 
neurological improvement (71.7 vs. 37.9%, p < 0.001) and higher rates of good func-
tional short- and mid-term outcome (58.3 vs. 23.7%, p < 0.001 and 71.4 vs. 41.7%, 
p < 0.001). However, while iSCI patients, in general, had a more favorable outcome, 
considerable heterogeneity in outcome was observed.
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conclusion: High rates of successful reperfusion (TICI 2b/3) and in particular, complete 
reperfusion (TICI 3) are associated with iSCIs. The high prevalence of iSCI in successfully 
reperfused patients with good collaterals corroborates previous concepts of iSCI patho-
genesis. iSCI, once considered a rare pattern of cerebral ischemia, is likely to become 
more prevalent with increases in endovascular stroke therapy. This may have implications 
for patient rehabilitation and pathophysiological analyses of ischemic damage confined 
to subcortical regions of the MCA territory.
Keywords: stroke, striatocapsular infarcts, thrombectomy, endovascular, basal ganglia, prevalence
inTrODUcTiOn
Striatocapsular infarcts (SCIs) are defined as large subcortical 
infarcts in the territory of the lenticulostriate perforator arter­
ies (1). They are caused by a simultaneous blockage of multiple 
neighboring perforators owning to a transient or permanent 
blockade of the proximal middle cerebral artery (MCA) or the 
carotid T (1–5). Thus, their pathogenesis and underlying risk 
factors differ from those of lacunar infarcts that are caused by 
an acute disruption of a single perforator due to hypertensive 
lipohyalinosis (6–8).
Because the striatocapsular territory lacks a collateral sup­
ply, the development of ischemia in the striatocapsular regions 
following proximal MCA occlusions is determined by the exact 
thrombus location and subsequent involvement of the perfora­
tors (9, 10). In contrast, the variability in preservation of the 
peripheral hemispheric tissue following large vessel occlusion 
(LVO) is mainly attributable to different degrees of collateral­
ization (11, 12) and highly dependent on the level of reperfusion 
(8, 13–16). This suggests that while the volume of more peri­
pheral, cortical infarct depends on both, the extent of reperfu­
sion and the time until reperfusion, striatocapsular infarction 
is likely to be time and reperfusion independent (10). Isolated 
striatocapsular infarction (iSCI) should then be encountered 
more commonly in the setting of highly effective reperfusion 
therapy.
Prior to the advent of effective reperfusion therapy iSCI was 
rarely observed, with a reported prevalence in large published 
stroke registries ranging from less than 0.01 to 6% (1, 4, 17–21). 
Successful reperfusion is considered necessary for the develop­
ment of iSCIs (22), and a recent study suggesting iSCI is more 
prevalent in patients treated with intravenous tPA (IV­tPA) 
supports this notion (23). However, IV­tPA has limited efficacy 
in LVOs (24, 25). Endovascular thrombectomy (ET) is now 
established as a highly effective reperfusion strategy for LVOs of 
the anterior cerebral circulation (26). To date, iSCIs have not been 
assessed previously together with angiographically confirmed 
reperfusion or more broadly in ET. This study aims to investigate 
the prevalence of iSCI in isolated proximal MCA occlusions 
treated with ET. Further, we assessed baseline and procedural 
characteristics associated with its occurrence and described the 
clinical course of iSCI patients. As ET of LVOs is expected to 
increase, this may have important implications for not only acute 
stroke management but also patient rehabilitation and may give 
insights into the pathophysiological processes underlying isolated 
ischemia of distinct parts of the caudate nucleus, striatum, and/or 
the internal capsule.
MaTerials anD MeThODs
Patient Population
Consecutive patients with isolated MCA occlusion who were 
subjected for ET at our institution between 01/2007 and 06/2016 
were included in the screening of potentially eligible patients 
(n = 409, see study flowchart displayed in Figure 1). All patients 
with adequate imaging to assess the extent of the infarction 
(defined as either MRI at day 3 or CT >18 h after symptom onset) 
were included (n = 337). Two patients in whom an MCA occlu­
sion occurred during the treatment of vasospasm were excluded, 
as were nine patients in whom recurrent stroke biased clinical 
assessment and one patient in whom hypoxic brain damage 
occurred following pulmonary artery embolism. Further, we 
excluded patients presenting with a distal MCA occlusion, 
defined as sparing of the lenticulostriate arteries. The final analy­
sis included 206 patients. The study was performed with the eth­
ics approval from the local ethics committee. Written informed 
consent was waived due to its retrospective design according to 
the institutional guidelines.
endovascular Therapy
According to our institutional guidelines, all stroke patients with 
CTA­proven LVO were eligible for ET in the absence of evidence 
of extensive early infarction on CT (involving more than one­
third of the MCA territory) and if the time from symptom onset 
to treatment was less than 6 h. No other image­guided selection 
or age limit was applied. Preinterventional intravenous recom­
binant tissue plasminogen activator (IV rtPA) was administered 
as bridging therapy in the absence of contraindications (n = 137; 
66.5%). Procedures were performed under general anesthesia 
or conscious sedation. In the vast majority of patients (n = 167; 
76.6%), thrombectomy was performed with the use of stent 
retrievers. Other applied techniques consisted of sole aspira­
tion (n = 8) or a combination of aspiration and stent retriever 
(n = 10). In six patients, a permanent stent was implanted because 
of an underlying high­grade MCA stenosis. Eighteen patients 
were treated with earlier generation devices/techniques (e.g., 
the MERCI retriever or intra­arterial rtPA). Three patients with 
spontaneous vessel recanalization, as revealed by first diagnostic 
DSA runs, were also included in the analysis.
FigUre 2 | Imaging examples of isolated (iSCI) and non-isolated 
striatocapsular infarct (niSCI). Left column, non-contrast CT; middle column, 
axial diffusion-weighted imaging; right column, coronar diffusion-weighted 
imaging. (a) iSCI; (B) niSCI.
FigUre 1 | Study flowchart. MCA, middle cerebral artery; iSCI, isolated striatocapsular infarct; niSCI, non-isolated striatocapsular infarct.
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imaging assessment
Two neuroradiologists independently classified striatocapsu­
lar territory infarction on postinterventional MRI (n  =  104, 
50.5%) or non­contrast CT (NCT, n =  102, 49.5%) blinded to 
all clinical data. Postinterventional NCT was usually performed 
at 12 h postintervention and at day 3 after endovascular treat­
ment. Median time from intervention to MRI was 3  days 
[interquartile range (IQR) 1–4  days]. A consensus read was 
used in cases of disagreement. With exception of small punctual 
embolic ischemia, as evaluated on MRI, the absence of acute 
ischemic lesions other than striatocapsular lesions was defined 
as isolated SCI (iSCI, Figure 2A). Concomitant involvement of 
the more peripheral MCA territory was rated as non­isolated 
SCI (niSCI, see Figure  2B). Symptom­onset­to­treatment time 
(SOTT) and symptom­onset­to­reperfusion time (SORT) 
were defined as time interval between symptom onset to first 
intracranial DSA series or substantial reperfusion, respectively. 
Thrombolysis in cerebral infarction (TICI)­graded reperfusion 
success was assessed by two neuroradiologists independently, 
with TICI 2b defined as reperfusion of more than 66% of the 
initially involved territory, according to the original TICI scale 
(27). Successful reperfusion was defined as TICI 2b/3. TICI 3 
reperfusion was referred to as complete reperfusion. Thrombus 
location within the MCA was dichotomized in proximal and 
distal occlusion (involving/sparing the lenticulostriate arteries, 
respectively). Only proximal occlusions were included into the 
analyses (see Patient Population). Hemorrhagic infarctions (HIs) 
and parenchymal hematomas (PHs) on postinterventional 
imaging were evaluated according to the ECASS criteria (28). 
Preinterventional collateral grading was performed using a 4­step 
grading system (0–3) as applied by the MR CLEAN investigators 
(29, 30). In short, 0 refers to 0% filling of the occluded territory, 
1 refers to poor collaterals with >0% but ≤50% filling of the 
occluded territory, 2 refers to moderate collaterals with >50% 
but <100% filling of the occluded territory, while 3 describes 
good collaterals with 100% filling of the occluded territory. Only 
mothership patients with available high quality single­phase CTA 
were graded (n = 108, 52.5%).
clinical assessment
Baseline and laboratory findings were extracted by reviewing 
patients’ medical charts. Clinical outcome was assessed by a 
TaBle 1 | Baseline and procedural characteristics.
isci (n = 53) nisci (n = 153) p
Age 72.3 ± 16.7 70.6 ± 14.3 0.532
Sex, female 60.4% (32) 56.9% (87) 0.747
Diabetes 11.3% (6/53) 21.3% (32/150) 0.151
Hypertension 69.8% (37/53) 75.3% (113/150) 0.469
Atrial fibrillation 54.7% (29/53) 50.7% (76/150) 0.635
Previous stroke 13.2% (7/53) 19.3% (29/150) 0.404
Admission glucose (mg/dl) 122 (109–147) 128 (109–156) 0.469
Baseline NIHSS 14 (12–17) 15 (12–18) 0.063
IV rtPA 77.4% (41) 62.7% (96) 0.063
Wakeup stroke 3.8% (2) 7.2% (11) 0.522
Collaterals (0–3) n = 108 2 (2–3) 2 (1–2) 0.045*
SOTT (min) 212 (168–263) 210 (165–270) 0.633
SORT (min) 263 (191–311) 277 (226–331) 0.287
Successful reperfusion (TICI 2b/3) 98.1% (52) 71.2% (109) <0.001**
Complete reperfusion (TICI 3) 66.0% (35) 31.4% (48) <0.001**
Modality used for classification, 
MRI
60.4% (32) 47.1% (72) 0.112
Data are displayed as % (n) or median (interquartile range).
iSCI, isolated striatocapsular infarct; niSCI, non-isolated striatocapsular infarct; SOTT, 
symptom-onset-to-treatment time; SORT, symptom-onset-to-reperfusion time; TICI, 
thrombolysis in cerebral infarction; IV rtPA, intravenous recombinant tissue plasminogen 
activator; NIHSS, National Institutes of Health Stroke Scale.
*p < 0.05.
**p < 0.01.
FigUre 3 | Frequency of isolated striatocapsular infarcts stratified with 
respect to reperfusion grades. iSCI, isolated striatocapsular infarct; niSCI, 
non-isolated striatocapsular infarct; TICI, thrombolysis in cerebral infarction.
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qualified neurologist using the National Institutes of Health 
Stroke Scale (NIHSS), Modified Rankin Scale (mRS), and Barthel 
index scores at the day of discharge (NIHSS­DIS, mRS­DIS, 
Barthel­DIS). A maximum NIHSS score was assigned to a fatal 
outcome during the acute hospital stay. “Substantial neurologic 
improvement” was prespecified as compound criterion of either 
(i) difference between admission NIHSS and NIHSS­DIS ≥8 
(ΔNIHSS ≥8), or (ii) NIHSS­DIS ≤1, as this dichotomization has 
been shown to be sensitive to detecting therapy effects in acute 
ischemic stroke (31). If available, short­ (n =  187, 90.8%) and 
mid­term functional outcome (n = 150, 72.8%) was assessed at 
discharge/day 90, and mRS≤ 2 was defined as “good func tional 
outcome.”
statistical analysis
Interrater reliability was evaluated using Cohen’s Κ. Continuous 
variables and frequency counts were compared using standard 
statistical measures (Welch’s t­test, Mann–Whitney U­test, 
and Fisher’s exact test). Data are shown as median and IQR or 
mean ± SD, if normally distributed. A second stroke after the 
index stroke was treated as an independent observation if the 
time difference between the two ischemic events was sufficient 
to allow adequate clinical distinction (≥6 months), as detected 
in three patients that were included in the analysis. Logistic 
regression modeling for factors associated with iSCI was per­
formed adjusting for age, and variables with p < 0.1 in univariate 
logistic regression. Logistic regression modeling was performed 
for all patients with complete data of the variables included and 
for a subset of patients in whom successful reperfusion was 
reached. Only in the latter model, the term TICI 3 reperfusion 
was included because of high collinearity with the binary vari­
able “successful reperfusion.” Data of logistic regression models 
are displayed as adjusted odds ratio (aOR) and 95% confidence 
interval (95% CI).
resUlTs
study Population
Two hundred and six patients were included in the final analysis 
(119 women; 57.8%). Mean age was 71.1 ±  14.9  years. Median 
NIHSS at presentation was 15 (IQR 12–18). Good functional out­
comes at discharge and at 90­day follow­up were noted in 32.6% 
(n = 61/187) and 50.0% (n = 75/150), respectively. In approximately 
one­quarter of the patients presenting with an acute proximal MCA 
occlusion (n = 53/206), the peripheral MCA territory was spared 
leading to an iSCI. Subsequently, niSCI was noted in 153 patients. 
Interrater reliability was excellent for both classification of iSCI 
(Κ >  0.9) and evaluation of reperfusion success using the TICI 
score (Κ > 0.9).
Factors associated with isci Occurrence: 
comparison of isci vs. nisci
Prevalence of iSCI varied between the different grades of 
reperfusion (see Figure  3, p <  0.001). Correspondingly, iSCI 
was observed more often in successfully reperfused patients 
(TICI  2b/3) as opposed to patients in whom successful rep­
erfusion could not be achieved (32.3 vs. 1.9%, p  <  0.001). 
Furthermore, iSCI occurred more often after complete reperfu­
sion (TICI 3) than after TICI 2b reperfusion (42.2 vs. 21.8%, 
p = 0.007). Comparing baseline and procedural characteristics, 
patients with iSCIs tended to have a lower baseline NIHSS scores 
(median 14 vs. 15, p =  0.063, see Table  1), better collaterals 
TaBle 3 | Outcome.
isci (n = 53) nisci (n = 153) p
HI 32.1% (17) 33.3% (51) 1.000
PH 1.9% (1) 5.2% (8) 0.452
In-hospital mortality 5.7% (3) 10.5% (16) 0.413
NIHSS-DIS 2 (0–7) 10 (5–15) <0.001**
Substantial neurologic 
improvement
71.7% (38) 37.9% (58) <0.001**
Barthel-DIS 45 (25–75) 15 (5–45) <0.001**
mRS-DIS 2 (1–4) 4 (3–5) <0.001**
Good functional short-term 
outcome (mRS-DIS ≤2)
58.3% (28/48) 23.7% (33/139) <0.001**
d90 mRS 1 (1–3) 3 (1–5) <0.001**
Good function mid-term 
outcome (d90 mRS ≤2)
71.4% (30/42) 41.7% (45/108) 0.002**
Data are displayed as % (n) or median (interquartile range).
HI, hemorrhagic infarction; PH, parenchymal hematoma; DIS, discharge; d90, day 90 
after admission; iSCI, isolated striatocapsular infarct; niSCI, non-isolated striatocapsular 
infarct; NIHSS, National Institutes of Health Stroke Scale; mRS, Modified Rankin Scale.
**p < 0.01.
TaBle 2 | Multivariate logistic regression.
adjusted 
odds ratio
95% 
confidence 
interval
p
Patients with available collateral data (n = 108)
Age 1.033 1.000–1.068 0.051
Intravenous recombinant tissue 
plasminogen activator (IV rtPA)
1.203 0.450–3.217 0.713
Baseline National Institutes of Health 
Stroke Scale (NIHSS)
1.060 0.937–1.200 0.352
Successful reperfusion [thrombolysis in 
cerebral infarction (TICI) 2b/3]
8.730 1.069–71.308 0.043*
Collaterals 2.100 1.119–3.944 0.021*
Patients with successful reperfusion and available  
collateral data (n = 86)
Age 1.011 0.881–1.161 0.872
IV rtPA 1.197 0.418–3.428 0.737
Baseline NIHSS 1.011 0.881–1.161 0.872
TICI 3 reperfusion 5.282 1.759–15.859 0.003**
Collaterals 2.385 1.135–5.010 0.022*
*p < 0.05.
**p < 0.01.
Adjusted odds ratios for collaterals refer to every grade increase.
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[median grade 2 (IQR 2–3) vs. 2 (IQR 1–2), p = 0.045] and had 
higher rates of successful (TICI 2b/3; 98.1 vs. 71.2%; p < 0.001) 
and complete (TICI 3; 60.4 vs. 39.6%; p < 0.001) reperfusions. 
Furthermore, IV rtPA bridging therapy tended to be more fre­
quently administered in iSCI patients (77.4 vs. 62.7%, p = 0.063). 
Both groups were comparable regarding risk factor profile, age, 
and admission laboratory findings. Symptom­onset to treatment 
and symptom­onset to reperfusion did not differ between both 
groups (median 212 vs. 210 min and median 263 vs. 277 min 
for iSCI vs. niSCI, respectively). In multivariate logistic regres­
sion analysis, successful reperfusion (TICI 2b/3) (aOR 8.730, 
95% CI 1.069–71.308) and good collaterals (aOR 2.100, 95% CI 
1.119–3.944) were associated with iSCI (see Table  2). In suc­
cessfully reperfused patients, TICI 3 reperfusions (aOR 5.282, 
1.759–15.859) were found as an additional factor associated with 
iSCI. When additionally entered in the model, symptom­onset 
to reperfusion was not associated with the occurrence of iSCI 
(aOR 1.001, 95% CI 0.997–1.005).
clinical Outcome
No significant difference was observed for the incidence of 
PH (1.9 vs. 5.2%, p =  0.452), HI (32.1 vs. 33.3%, p =  1.000) 
or in­hospital mortality (5.7 vs. 10.5%, p  =  0.413) when 
comparing iSCI and niSCI patients. Patients with iSCI had 
higher rates of good clinical outcome, specifically, higher 
rates of substantial neurologic improvement (71.7 vs. 37.9%, 
p <  0.001, see Table  3), higher median Barthel index scores 
at discharge (median 45 vs. 15, p  <  0.001) and higher 
rates of good functional short­ and mid­term outcome 
(58.3 vs. 23.7%, p < 0.001 and 71.4 vs. 41.7%, p < 0.001, respectively, 
see Figure 4). However, while iSCI patients in general had a more 
favorable outcome, considerable heterogeneity in outcome was 
observed (see Figures 4 and 5).
DiscUssiOn
This study demonstrates strong evidence for an association 
between the extent of reperfusion and the development of iSCI 
in MCA occlusions. This is the first study of iSCI reported to 
date in a large cohort of patients treated with ET in a single 
center. These results support the strong dependency of iSCI 
on vessel recanalization (23) and good collaterals and thus 
concur with current concepts of iSCI pathogenesis (3, 4, 32). 
iSCIs demonstrated strong evidence for an association with 
good functional outcome. Together, both the association with 
reperfusion and the association with good functional outcome 
may, at least in part, explain why reperfusion has recently been 
described as the critical driver of outcome in ET (26). This 
suggests that iSCIs may provide a distinct imaging correlate, 
which reflects the treatment superiority of ET in proximal MCA 
occlusions (33–37).
Our results further support the notion that achieving quality 
reperfusion and, at best, complete (TICI 3) reperfusion may be 
the most crucial determinant of favorable outcome (38, 39). The 
striatocapsular region may undergo infarction relatively early; 
owing to a lack of collateral pathways (9, 10). However, by achiev­
ing complete (TICI 3) reperfusion, there is greater likelihood of 
preserving the penumbral cortical tissue in comparison to less 
complete degrees of reperfusion.
At first, the lack of evidence for an association between iSCI 
and time to treatment may seem counterintuitive. Reduced time 
to groin puncture and time to reperfusion have demonstrated 
very strong evidence for associations with improved functional 
outcome (40, 41). However, it is important to note that patients 
may achieve good functional outcomes (mRS 0–2) while suf­
fering more extensive cerebral infarctions than iSCI. Indeed, 
the magnitude of effect of reduction in time to groin puncture 
or time to reperfusion in the recent thrombectomy trials is 
remarkably small (1–4% per 30 min reduction) (41). This may 
be explained by the incremental effect of preserving cortical 
FigUre 5 | Neurological symptom severity of patients with iSCIs vs. niSCIs at the day of discharge. iSCI, isolated striatocapsular infarct; niSCI, non-isolated 
striatocapsular infarct.
FigUre 4 | Short- and mid-term functional outcome of patients with iSCIs vs. niSCIs. Rates of good functional outcome were significantly higher in iSCI patients 
(p < 0.001). Discharge/day 90 mRS was available for 48/53 and 42/53 iSCI patients and 139/153 and 108/153 niSCI patients. iSCI, isolated striatocapsular infarct; 
niSCI, non-isolated striatocapsular infarct; mRS, Modified Rankin Scale.
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penumbra rather than the striatocapsular tissue. Interestingly 
van Overbeek and colleagues also found no evidence for an 
association between time to treatment with IV­tPA and iSCI (23). 
This time insensitivity may be explained by the sine qua nons 
condition of robust collaterals required in the pathogenesis of 
iSCI, which is supported by the presented data. Patients without 
7Kaesmacher et al. Isolated SCIs following Thrombectomy
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sufficient collateral supply may recruit cortical penumbra into 
the ischemic core early; precluding these patients from iSCI 
categorization. Patients with sufficient collateral supply to the 
cortical penumbra may be relatively insensitive to time, at least 
within the current study’s treatment window (123–717 min) and 
therefore achieve iSCI in the presence of quality reperfusion. 
Previous work has demonstrated that penumbral recruitment by 
the ischemic core occurs at a very slow rate in the presence of 
good collaterals (11), and the present study supported evidence 
that the specific association between collaterals and iSCI also 
holds true in the setting of ET.
To the best of our knowledge four major pathophysiologic 
processes have been proposed to cause iSCIs: (1) emboli to the 
proximal MCA (14, 42); (2) triangular­shaped carotid T occlu­
sion allowing cortical supply (1); (3) extracranial carotid artery 
occlusion with either presumed emboli to the proximal MCA 
or hemodynamic alterations leading to deep territory infarction 
(4, 32); (4) atherosclerotic disease of the MCA with concomitant 
in situ thrombosis or other isolated MCA abnormalities (dissec­
tion, vasculitis) (4, 32, 43). Emboli to the MCA were found to 
result in iSCI if the peripheral tissue is preserved by an outstanding 
collateral system, and in combination with/or if the occlusion is of 
transient nature, which might be due to spontaneous thromboly­
sis, IV rtPA induced thrombolysis (23) or, as shown here, with ET. 
In contrast to the reported recanalization rate of 78.2% within the 
presented study, early recanalization following IV rtPA was found 
to occur in approximately one­third of proximal MCA occlusions 
(44). The incidence of iSCI may thus increase considerably with 
the spread of endovascular therapy for LVOs.
It is plausible that iSCI patients had less neurological sequelae 
because all parts of the eloquent neocortex were spared. The 
generally more favorable outcome of patients with iSCI corrobo­
rates results from a meta­analysis of patients with iSCI reviewed 
by Caplan (45). On the other hand, it is evident that most patients 
with iSCI suffer from, albeit smaller, neurological symp toms, 
and some patients are functionally disabled. Further analyses of 
patients with this ischemic stroke pattern may elucidate underly­
ing pathophysiology or imaging correlates explaining this het­
erogeneity [e.g., grade of capsule ischemia and preexisting white 
matter lesions (20)]. Furthermore, patients with iSCI were found 
to frequently suffer from different degrees of less conspicuous 
neuropsychological dysfunctions (4, 46). This may be of relevance 
as more than half of the acute stroke patients who achieve an 
excellent functional outcome suffer from cognitive impairment, 
depression, or participation restriction within 3  years after the 
acute event (47).
The current study suggests that the once rare iSCIs are likely to 
increase in incidence as the number of endovascular thrombecto­
mies increases. Therefore, these patients warrant further study. It 
is likely, given the isolated involvement of subcortical structures, 
that these patients will require tailored subacute therapy and 
rehabilitation strategies. This may have significant implications 
for far ranging ischemic stroke services from the acute stroke unit 
to community­based rehabilitation and workplace reintegration. 
Furthermore, the increased incidence may allow for a more 
detailed pathophysiological analysis of ischemia confined to 
parts of the putamen, the caudate nucleus, or the internal capsule 
(e.g., subcortical aphasia, apathy, etc.).
The present study has a number of limitations, in general due 
to its retrospective nature: A considerable number of patients 
were excluded due to missing or inadequate imaging follow­up. 
This was especially an issue for patients treated before mid­2012, 
when institutional protocols required less imaging in patients 
with good neurological outcome. This may be a source of attri­
tion bias. Second, CT­derived definition of iSCI is susceptible 
to underestimation of infarct extent, which may introduce a 
detection bias for peripheral ischemia. However, CT­derived 
definitions of iSCI were based upon CTs on days 3–4 and were 
evaluated on 2.5 mm slices, reducing the rates of false positive 
ratings. Furthermore, outcome effects were observed independ­
ent of the imaging modality, on which the iSCI definition relies on 
(see Figure S1 in Supplementary Material). As both patients with 
iSCI and niSCI had a better outcome if they received an MRI scan 
instead of a CT scan (probably because MRI is clinically more 
feasible in patients doing well), it is unlikely that all heterogeneity 
within the iSCI group is introduced by false positive rating of 
iSCI in patients receiving a CT scan. Finally, functional mid­term 
outcome data were available only for 150/206 patients.
cOnclUsiOn
Successful reperfusion in patients presenting with a proximal 
MCA occlusion and robust collaterals markedly favors occurrence 
of iSCIs. Considering the widespread use of ET in clinical practice, 
the incidence of this stroke pattern is likely to rapidly rise. The 
patient group with iSCI was found to have a very benign, albeit 
heterogeneous, short­ and mid­term clinical course. Further 
research may elucidate the pathophysiological role and corre­
sponding imaging correlates of isolated striatocapsular ischemia 
and may further initiate a discussion about deliberate follow­up 
and rehabilitation strategies for this particular patient group.
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